type, podocytes exit the cell cycle and cease proliferating (p21, p27, p57) in general prevent proliferation by inhibiting so that mature podocytes exhibit a quiescent phenotype cyclin-CDK complexes. In the current study, we determined [3, 4] . The podocyte response to injury in glomerular the expression and possible role of specific CDK inhibitors disease includes flattening and effacement of foot proin podocyte proliferation in human disease characterized by cesses, and in more severe injury, this is associated with podocyte injury.
podocyte detachment from the underlying glomerular Methods. Immunostaining was performed for the CDK inhibitors p21, p27, and p57 and the proliferation marker basement membrane [1] . Recently, potential proliferaon renal biopsies from patients with minimal change disease tive responses of mature podocytes to injury have been (MCD; N ϭ 6), membranous glomerulopathy (MGN; N ϭ 19), recognized and are a subject of considerable debate [5] . cellular variant of focal segmental glomerulosclerosis (FSGS; In glomerular diseases in which the podocyte is a pri-N ϭ 12), collapsing glomerulopathy (CG; N ϭ 9), and HIVmary target of injury, such as minimal change disease associated nephropathy (HIVAN; N ϭ 16). Adult nephrectomy (MCD) and membranous nephropathy [6] , it is generally specimens without evidence of glomerular disease served as controls (N ϭ 9).
accepted that podocytes do not re-engage the cell cycle
Results. Normal quiescent podocytes express p27 and p57, and maintain their terminally differentiated phenotype.
but not p21. In diseases without podocyte proliferation (MCD, In some forms of focal segmental glomerulosclerosis MGN), p21, p27, and p57 expression did not change. In con-(FSGS), podocytes detach from the underlying glomerutrast, there was a uniform decrease in p27 and p57 immunolar basement membrane following injury. Studies have staining in diseases with podocyte proliferation (cellular FSGS, shown that the inability of podocytes to proliferate and CG, and HIVAN). This was accompanied by the de novo expression of p21 in podocytes.
replace those lost in this injury process may result in a Conclusions. Our results show that podocyte quiescence may denuded glomerular basement membrane, which leads require the presence of the CDK inhibitors p27 and p57. In to the development of glomerulosclerosis [7] [8] [9] .
human glomerular diseases, a decrease in p27 and p57 may be More recently, it has been recognized that podocytes permissive for the altered proliferative podocyte phenotype. p21 proliferate in response to certain forms of injury. The celmay have a multifactorial role in podocyte cell cycle regulation. lular variant of FSGS [10] , collapsing glomerulopathy (CG) [11] [12] [13] , and HIV-associated nephropathy (HIVAN) [11] are characterized by glomerular cell proliferation. The been suggested that these cells may be monocytes arising
The subgroups of cellular FSGS and CG were defined according to previously described morphologic and clinifrom transformed podocytes [14] .
Cell proliferation and, to some extent, cell differentiacal features [11] . All patients with CG had negative HIV serologies. In all patients with HIVAN, diagnosis was tion are controlled at the level of the cell cycle by cell cycle-regulatory proteins. Proliferation requires that speconfirmed by demonstration of serum antibodies to HIV-1 using enzyme-linked immunosorbent assay (ELISA) cific cyclin-dependent kinases (CDKs) are activated by a partner cyclin in each phase of the cell cycle [16] . Thus, followed by Western blot. For control tissues without glomerulopathy, macroscopically normal-appearing re-CDK4 and CDK6 are activated by D-type cyclins in early G 1 phase of the cell cycle. CDK2 is activated by cyclin nal tissues were obtained from nephrectomies (N ϭ 9) performed for localized renal cell carcinoma, at sites E in late G 1 and by cyclin A in the S phase of DNA synthesis, and cdc2 (formerly CDK1) is bound by cyclin away from the tumor. The number of glomeruli from each case was counted on light microscopy, and the num-B in mitosis [reviewed in 17, 18] . Cyclin-CDK complexes, in turn, are negatively regulated by CDK inhibitors [19] .
ber of injured glomeruli was recorded in focal glomerular diseases (FSGS, HIVAN, and CG). The Cip/Kip family of CDK inhibitors, which include the individual proteins called p21
Cip1/WAF1 (p21) [20, 21] , Antibodies used p27 Kip1 (p27) [22, 23] , and p57 Kip2 (p57) [24] , inhibits cyclin D-CDK4 and cyclin E-CDK2 in G 1 and cyclin A-CDK2
The following primary antibodies were used: (1) p21
Cip1/Waf1 (p21), a mouse monoclonal antibody (clone in S phase. Recent studies have shown that p21 also limits cyclin B-cdc2 in mitosis [25] . The CDK inhibitors SX118; Pharmingen, San Diego, CA, USA) was raised against a purified recombinant human p21-GST fusion p21, p27, and p57 are constitutively expressed in certain cell types, and there is a growing body of evidence that protein The purpose of the current study was to examine which Biotechnology, Santa Cruz, CA, USA) that maps to an epitope to the carboxy terminus of p27 and has been cell cycle-regulatory proteins contribute to the maintenance of a differentiated and quiescent podocyte phenocharacterized by Western blot analysis [31, 32] . In the current study, staining was abolished by preabsorbing type in certain forms of glomerular disease and which contribute to processes of de-differentiation and prolifthe antibody with immunizing peptide (Santa Cruz Biotechnology). (3) p57 Kip2 (p57; C-20 Santa Cruz Biotecheration in other forms of injury. We examined the expression of the Cip/Kip CDK inhibitors p21, p27, and p57 nology) is a rabbit polyclonal antibody raised against a peptide corresponding to amino acids 286 to 305 of the in different human glomerular diseases in which podocytes are the major target of injury. p27 and p57 are carboxy terminus of human p57. This antibody has been previously characterized by immunoblotting and immuconstitutively expressed in mature podocytes, but p21 is not (in agreement with previous studies by ourselves [27] nohistochemistry [28] . In the current study, immunostaining was abolished by preabsorbing the antibody with and others [28] ). A decrease in these levels of p27 and p57 and a corresponding de novo expression of p21 cointhe immunizing peptide (Santa Cruz Biotechnology). (4) Ki-67, clone MIB-1, is a murine monoclonal antibody cide with podocyte proliferation and an immature phenotype.
(Coulter/Immunotech, Miami, FL, USA) that reacts with the proliferation-associated Ki-67 antigen and has been previously shown to correlate with DNA synthesis after METHODS antigen retrieval.
Source of tissue
Immunostaining Cases of minimal change disease (MCD; N ϭ 6), cellular FSGS (N ϭ 12), collapsing glomerulopathy (CG; N ϭ
Immunohistochemistry was performed on formalinfixed, paraffin-embedded tissue sections following proto-9), and human immunodeficiency virus-associated nephropathy (HIVAN; N ϭ 16) were selected retrospeccols that we have previously reported [27] . Four-micron thick sections of tissue samples were deparaffinized in tively from the archives of the Renal Pathology Laboratory of Columbia University. All biopsies had been xylene and rehydrated in graded ethanols. Endogenous peroxidase was blocked by incubation in 3% hydrogen performed in the two-year period of 1998 to 1999. Cases of membranous glomerulopathy (MGN; N ϭ 20) were peroxide. Sections were pretreated by steam heating for 20 minutes in Antigen Unmasking Solution (Vector Labselected retrospectively from the archives of the University of Washington Renal Pathology Laboratory. All paoratories, Burlingame, CA, USA) according to the manufacturer's instructions. Non-specific antibody binding tients were biopsied for investigation of nephrotic proteinuria, with or without associated renal insufficiency.
was blocked by incubation for 30 minutes in 10% normal 1E ) and was also not detected in MCD (results not shown) and membranous nephropathy (Fig. 3E ). mal rabbit serum (for polyclonal antibodies). The tissue In contrast, there was a marked increase in glomerular sections were then incubated for one hour at room temimmunostaining for Ki-67 in the cellular variant of FSGS perature (p27, p57, Ki-67) or overnight at 4ЊC (p21) (Fig. 4E) , CG, and HIVAN (Fig. 5E ). In glomeruli in with the primary antibody diluted in phosphate-buffered which the features of collapse or of cellular FSGS were saline (PBS) plus 1% bovine serum albumin (BSA; segmentally distributed, the expression of the Ki-67 antiSigma, St. Louis, MO, USA). After PBS washes, tissue gen was also segmentally distributed and corresponded sections were incubated sequentially with a biotinylated to the histologic alterations. Our results showed that Ki-67 secondary antibody, the ABC-Elite Reagent (Vector staining divided diseases of the podocyte into those in Laboratories) and with 3.3Ј-diaminobenzidine with nickel which the podocyte maintained a differentiated and quichloride enhancement. A methyl green nuclear counter escent phenotype (MCD, membranous nephropathy) stain was used. Tissue from placenta and colon were and those diseases associated with a de-differentiated used as positive controls for the antibodies to p21 and and proliferative phenotype (cellular variant of FSGS, p57 [33] . Human fetal kidney was used as a positive CG, and HIVAN). control for p27 and p57, as previously described [27, 28] .
Negative controls for immunostaining consisted of Differential expression of CDK inhibitors in normal substituting the primary antibody with an irrelevant isohuman glomeruli type-matched murine monoclonal antibody (Dako, CarImmunostaining for p57 was abundant and restricted pinteria, CA, USA) or nonimmune rabbit serum (Dako).
to normal podocytes and was not present in glomerular Jones' silver methamine staining was performed on hismesangial and endothelial cells (Fig. 1B) . The CDK intologic sections from all cases using conventional procehibitor p27 is constitutively expressed in normal human dures.
glomeruli (Fig. 1C) . Although positive nuclear staining was rarely detected in all three resident glomerular cell types in normal kidneys, immunostaining for p27 was RESULTS abundant in podocytes (Fig. 1C) .
Ki-67 immunostaining separates different types of
Immunostaining for p21 was not detected in normal glomerular diseases glomeruli (Fig. 1D) . Positive controls included concur- Table 1 shows the total number of glomeruli examined rent p21 immunostaining in tubulointerstitial cells and in each glomerular disease, the average number of gloin the smooth muscle cells in small arteries in the same meruli studied in individual cases, and the percentage tissue sections and demonstration of p21 expression in of glomeruli with disease in the focal diseases. We stress simultaneously processed, and stained tissue sections that the immunostaining patterns described later in this from placenta where p21 expression have been well dearticle were homogeneous for all glomeruli in the cases fined [30, 33] . of MCD and membranous glomerulonephritis and were Expression of CDK inhibitors in nonproliferative homogeneous in those glomeruli or segments of glomerglomerular diseases (MCD and MGN) uli exhibiting the characteristic pathology of cellular FSGS, CG, and HIVAN, as illustrated in Figures 1-5 .
Podocyte expression of p27 and p57 was well preTo determine the presence of DNA synthesis and enserved in all glomeruli in MCD (Fig. 2) and MGN (Fig. try into S phase of the cell cycle, tissue sections were 3). The glomerular expression of p21 was undetectable stained with an antibody to the proliferation antigen Ki-67.
in these diseases (Figs. 2 and 3) . These results show that the glomerular expression of the CDK inhibitors p21, Ki-67 immunostaining was absent in normal podocytes p27, and p57 was indistinguishable from normal adult decrease in intensity of p57 staining in glomeruli in which nephrectomy specimens that did not have glomerular proliferation was not pronounced (results not shown). disease (Fig. 1) .
In areas of proliferation, there was a segmental absence of podocyte immunostaining for p57. The absence was Expression of CDK inhibitors in proliferative not due to cell loss, as nuclei were easily detected by the glomerular diseases (cellular FSGS, CG, and HIVAN) methyl green counterstain. In many glomeruli in which serial sections were available, there was a concordant Changes in p57 staining were also associated with podocyte proliferation (Figs. 4 and 5 ). There was a general decrease/absence of p27 and p57 immunostaining in identical segmental areas of proliferation in cellular staining. Nuclear immunostaining for p21 was detected in FSGS, CG, and HIVAN (Figs. 4 and 5) .
podocytes and in mesangial and glomerular endothelial In contrast to the nonproliferative glomerular discells. eases, there was a marked decrease in staining intensity for p27 in the majority of glomeruli in patients with the DISCUSSION cellular variant of FSGS (Fig. 4C) , CG, and HIVAN The mature podocyte is a terminally differentiated cell (Fig. 5C ), including glomeruli without histologically that expresses specific differentiation markers, including identifiable lesions. Moreover, p27 immunostaining was GLEPP-1, WT-1, C3b receptor, podocalyxin, and synapnot detected in segmental areas of podocyte proliferatopodin [reviewed in 34]. In contrast to immature podotion. Careful inspection of biopsies treated with nuclear cytes, which proliferate during glomerular development counterstained methyl green showed that the decrease in utero, differentiated podocytes have a quiescent pheor absence of p27 immunostaining was not due to the notype [2] . The maintenance of a differentiated phenoloss of podocyte number, but rather due to an absolute type is required for podocytes to perform their specialdecrease in nuclear staining.
ized functions [1] . The current study provides important There was a marked increase in p21 immunostaining in evidence that human podocyte differentiation and prolifthe cellular variant of FSGS (Fig. 4D) , CG, and HIVAN eration in vivo may depend on the levels of specific CDK (diseases characterized by podocyte proliferation; Fig. inhibitors. Our results show that the CDK inhibitors p27 5D). In these cases, the de novo staining for p21 was in and p57, but not p21, are constitutively expressed in a segmental pattern, which spatially coincided with the segmental decrease/absence of p27 and p57 immunonormal differentiated podocytes, and persistent expres- sion of these molecules following injury is associated entially expressed in normal human podocytes. Both p27 and p57 are constitutively expressed in mature podowith the persistence of a quiescent (nonproliferative) phenotype. In contrast, glomerular diseases associated cytes, where the CDK inhibitor p21 is not detected. These findings are consistent with previous studies by with a decrease in podocyte expression of p27 and p57 lose the mature phenotype and acquire a proliferative our group and others showing that podocyte differentiation and exit from the cell cycle during glomerulogenesis and immature phenotype.
In the current study, it was found that individual procoincides with the de novo expression of p27 and p57, but not p21 [27, 28] . teins of the Cip/Kip family of CDK inhibitors are differ- Podocytes maintain a differentiated and nonproliferaforms of glomerular disease, including HIVAN [11] . A second major finding in this study was that the immunotive phenotype in MCD and membranous nephropathy. In contrast, podocytes re-enter the cell cycle and acquire staining for the CDK inhibitors p27 and p57 did not decrease in MCD. Furthermore, p27 was not altered in a proliferative phenotype in the cellular variant of FSGS [10] , idiopathic CG [11] , and HIVAN [11] resembling membranous nephropathy, although there was a decrease in the intensity of p57 immunostaining in podoan immature phenotype. Moreover, Barisoni et al have shown that podocyte proliferation is associated with a cytes in some biopsies exhibiting membranous nephropathy. In contrast, there were two patterns of p27 and p57 loss of the differentiated markers such as WT-1 in certain expression noted in cellular FSGS, CG, and HIVAN. not due to a loss of cell number because podocyte nuclei were present and easily identified in the conventionally First, there was a segmental absence of immunostaining for both p27 and p57 in a distribution that was nearly stained histologic preparations. These findings support a paradigm in which the reduction in p27 and p57 preidentical to that of Ki-67 expression in areas of podocyte DNA synthesis in individual glomeruli. Second, histologcedes the development of histologically identifiable glomerular lesions. ically "normal" glomeruli present in cases of cellular FSGS, CG, and HIVAN demonstrated a general deExperimental studies also have shown a role for p27 in podocyte proliferation. A lack of podocyte proliferacrease in staining intensity for p27 and p57 in the podocytes. The decrease in p27 and p57 immunostaining was tion in the passive Heymann nephritis model of experi-mental membranous nephropathy coincides with inmesangial cell proliferation. The absence of podocyte creased p27 levels in injured podocytes [35] . It has been proliferation in experimental membranous nephropathy shown that p27 binds to and inhibits CDK2 activity in (passive Heymann nephritis model) also coincides with a experimental membranous nephropathy, thereby limmarked increase in p21 expression, and lowering p21 levels iting podocyte proliferation [35] . Immune-mediated glowith the mitogenic growth factor basic fibroblast growth merulonephritis in p27 null mice is associated with infactor in rats with passive Heymann nephritis are associcreased glomerular cell proliferation compared with ated with low-grade podocyte proliferation [35] . Finally, controls, and the proliferating cells in nephritic p27 null we have recently shown that podocyte proliferation is mice were typically podocytes [36] . Taken together, the markedly increased in experimental glomerulonephritis current study shows that p27 levels may have a critical in mice made genetically deficient in p21 (p21Ϫ/Ϫ) comrole in podocyte differentiation and proliferation in hupared with nephritic p21ϩ/ϩ mice [40] . man glomerular disease. The persistence/maintenance of Second and mechanistically more confusing is that rep27 expression in MCD and membranous nephropathy cent studies have shown that small increases in p21 levels was associated with and may be responsible for a differmay serve to facilitate proliferation by providing a "scafentiated and quiescent podocyte phenotype, whereas a fold-like" function for the assembly of cyclins, CDKs, decrease in p27 levels in the cellular variant of FSGS, and proliferating cell nuclear antigen [41] . Thus, one may collapsing GN, and HIVAN is closely correlated with speculate that the increase in p21 in certain podocyte podocyte proliferation and may be necessary for these diseases facilitates proliferation in the absence of other processes to develop.
CDK inhibitors such as p27 and p57. Third, Nagata et The CDK inhibitor p57 also regulates cell proliferation al has shown that p21 is transiently increased during and differentiation [37] . p57 is typically expressed in podocyte development so that the increased expression differentiated and postmitotic nonrenal cells [24] , and could be a manifestation of an immature phenotype, indewe (unpublished data) and others have shown that there pendent of its regulatory role for cell proliferation [28] . is de novo expression of p57 in podocytes during glomerIn summary, the results of the current study show a ulogenesis that coincides with p27 expression and with role for specific cell cycle proteins in glomerular disease podocyte acquisition of a terminally differentiated phecharacterized by podocyte injury. In diseases characternotype. In the current study, we show that a decrease ized by podocyte proliferation, the decreased expression or absence of p57 immunostaining was associated with of specific CDK inhibitors is similar to their pattern of an immature and proliferative podocyte phenotype in expression during early podocyte development. The corhuman disease. However, a decrease in p57 immunoollary of this is also true in that we show that the presence staining alone, suggestive of diminished but not absent of the CDK inhibitors p27 and p57 is associated with the levels of p57 peptide, was apparent in membranous nepersistence of a differentiated and quiescent podocyte phropathy without a concomitant decrease in p27 levels.
phenotype, and is consistent with the general notion that This constellation of findings was not sufficient for dethe principal function of these molecules is to inhibit cell monstrable proliferation. Taken together, our results inproliferation. Recent evidence that p21, often considered dicate that the inhibitory threshold imposed by both p27 and p57 needs to be overcome in order for podocytes to function as a suppressor of cell proliferation like p27 to proliferate and acquire an immature phenotype. and p57, has more complex biologic functions that include A third and surprising major finding in the current facilitation of cell proliferation, is further supported by study was that the pattern of expression for the CDK our demonstration that p21 expression in podocytes is inhibitor p21 was different from p27 and p57. Immunoassociated with a pro-proliferative antiquiescent effect. staining for p21 was absent in normal glomeruli and did
The potential diagnostic implications of this study is that not increase in MCD and membranous nephropathy. In determining the expression of specific cell cycle proteins contrast to p27 and p57, p21 expression increased during may assist in differentiating the different forms of podopodocyte proliferation in the cellular variant of FSGS, cyte diseases. collapsing GN, and HIVAN. We can only speculate on [39], increased p21 levels are associated with a lack of
